SOD1 and esophageal squamous cell carcinoma: When compared to patients with low serum SOD activity, this retrospective analysis showed that while high serum SOD activity may enhance post-radiotherapy quality of life in esophageal squamous cell carcinoma (ESCC) patients, it does not substantially increase patient survival [129].